Suppr超能文献

类固醇抵抗型肾病综合征:组织病理学的作用

Steroid resistant nephrotic syndrome: role of histopathology.

作者信息

Gulati Sanjeev, Sengupta Debashish, Sharma Raj K, Sharma Ajay, Gupta Ramesh K, Singh Uttam, Gupta Amit

机构信息

Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

出版信息

Indian Pediatr. 2006 Jan;43(1):55-60.

Abstract

This study was conducted to (1) see the histopathological distribution of different subtypes in steroid resistant nephrotic syndrome (SRNS) and (2) compare the clinical, biochemical parameters and outcome between Minimal Change Disease (MCD) with non-MCD subtypes in response to immunosuppressive therapy. A retrospective analysis was done of data on all biopsy proven children with idiopathic SRNS (no response to 4 weeks of standard prednisone therapy (60 mg/m(2)/day)) referred to our institute over last 12 years. They were treated with one of the following medications: oral or intravenous cyclophosphamide, cyclosporine or combination of dexamethasone and azathioprine. A comparison was done of the demographic clinical and biochemical features different histopathologies. We studied 136 children with SRNS (100 M, 36 F). They accounted for 15.1%(136/900) of all children with idiopathic nephrotic syndrome. Focal segmental glomerulosclerosis (FSGS) was the commonest 80/136 (59%), followed by MCD (17.6%). Children with non-MCD had a significantly greater prevalence of microhematuria as compared to MCD. The other baseline clinical and biochemical features including the glomerular filtration rate (GFR) were similar. After a mean follow up of 46 (8-148) months, a significantly greater children with non-MCD 65/112) continued to be proteinuric as compared to the MCD (3/24) (p=0.0001). FSGS was the commonest cause of SRNS in our patient population. Children with SRNS secondary to MCD are more likely to achieve remission as compared to non-MCD subtypes and have a better long-term prognosis. Hence kidney biopsy is of significant prognostic value in SRNS.

摘要

本研究旨在

(1)观察不同亚型在激素抵抗型肾病综合征(SRNS)中的组织病理学分布;(2)比较微小病变性肾病(MCD)与非MCD亚型在免疫抑制治疗反应方面的临床、生化参数及预后情况。对过去12年转诊至我院的所有经活检证实的特发性SRNS患儿(对4周标准泼尼松治疗(60mg/m²/天)无反应)的数据进行回顾性分析。他们接受了以下药物之一的治疗:口服或静脉注射环磷酰胺、环孢素或地塞米松与硫唑嘌呤的联合用药。对不同组织病理学的人口统计学、临床和生化特征进行了比较。我们研究了136例SRNS患儿(100例男性,36例女性)。他们占所有特发性肾病综合征患儿的15.1%(136/900)。局灶节段性肾小球硬化(FSGS)最为常见,为80/136(59%),其次是MCD(17.6%)。与MCD相比,非MCD患儿镜下血尿的患病率显著更高。其他基线临床和生化特征,包括肾小球滤过率(GFR)相似。平均随访46(8 - 148)个月后,与MCD患儿(3/24)相比,非MCD患儿(65/112)持续蛋白尿的比例显著更高(p = 0.0001)。FSGS是我们患者群体中SRNS最常见的病因。与非MCD亚型相比,继发于MCD的SRNS患儿更有可能实现缓解,且长期预后更好。因此,肾活检在SRNS中具有重要的预后价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验